A single-dose oral antibiotic from a new class of drugs was as effective as the previous standard of care at treating ...

SAMHSA, amid continuing crises in mental health and addiction, has been hit by heavy cuts in personnel and funding under ...

The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...

Is a new obesity drug making people lose too much weight? Plus catch up on #ASH25 and hear how the country's scientific ...

Democratic and Republican proposals on health insurance voted down as year-end expiration of subsidies draws closer.

European policymakers unveiled an agreement for the biggest shakeup to E.U. pharmaceutical policy in two decades.

Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential #ASH25 medical conference.

Eli Lilly’s next-generation obesity drug led to what appears to be the most weight loss seen so far in a late-stage trial, ...

In the past twenty years, the number of hospitals that are capable of treating kids and adolescents has dropped significantly ...

Leading efforts to translate research into treatments at the NIH had felt, for physician Josh Fessel, like the way he could ...

At a health care AI summit in Washington D.C. yesterday, heavy hitters weighed in on the prospects for interoperability — the ...

AC Immune said its immunotherapy showed the potential to slow the progression of Parkinson’s disease, based on preliminary ...